ABL Diagnostics S.A. (ABLD)
Euronext
2.20
-0.02 (-0.90%)
Closed
Oct 8, 2026
Day's Range
2.102.22
52 wk Range
2.105.00
Financial Statements - ABLD - ABL Diagnostics S.A.
Revenue
6.95M▲ 30.4%
Net Income
986.69K▲ 246.0%Net Margin 14.2%
EBITDA
1.02M▲ 205.8%
Free Cash Flow
714.76K▲ 130.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 6.95M | 5.33M | 5.61M | 8.74M | 0 | 0 |
| Cost of Goods | 327.43K | 494.24K | 734.53K | 426.69K | 101.63K | 87.20K |
| Gross Profit | 6.62M | 4.83M | 4.87M | 8.32M | -101.63K | -87.20K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 290.49K | -484.19K | -657.08K | 59.28K | -102.62K | -91.16K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 328.80K | -496.27K | -670.91K | 77.49K | -102.61K | -89.29K |
| Income Tax | -657.88K | -722.14K | -678.21K | -615.15K | 38.08K | - |
| Net Income | 986.69K | 285.17K | 54.36K | 1.10M | 257.86K | -89.29K |
| EPS Basic | - | 0.017716 | 0.003374 | 0.068616 | 0.128518 | -0.044504 |
| EPS Diluted | - | 0.017716 | 0.003374 | 0.068616 | 0.128518 | -0.044504 |
| Basic Shares Outstanding | - | - | 16.11M | 16.11M | 2M | 2M |
| Diluted Shares Outstanding | - | - | 16.11M | 16.11M | 2M | 2M |
| Ebit | 402.51K | -423.42K | -616.79K | 90.31K | -102.62K | -91.16K |
| Ebitda | 1.02M | 334.22K | 45.42K | 651.06K | -102.62K | -91.16K |
| Net Income Continuous Operations | 986.69K | 285.17K | - | - | 257.86K | -89.29K |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 2 | 0 | 1 | -1 | 1 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
